论文部分内容阅读
目的研究布地奈德治疗小儿呼吸道合胞病毒感染相关喘息的临床疗效。方法 100例呼吸道合胞病毒感染相关喘息患儿,依据治疗方法不同分为对照组(45例)和实验组(55例)。对照组采取常规治疗,实验组采取布地奈德治疗,对比两组治疗效果。结果实验组住院、喘息改善和呼吸改善、止咳化痰时间为(5.30±0.80)、(1.05±0.80)、(2.01±0.50)、(1.80±1.20)h,均短于对照组的(10.25±2.20)、(4.80±1.03)、(4.92±2.60)、(5.07±2.30)h,差异具有统计学意义(P<0.05)。对照组第1秒用力呼气容积(FEV1)、用力肺活量(FVC)、FEV1/FVC均显著低于实验组,差异具有统计学意义(P<0.05)。结论小儿呼吸道合胞病毒感染采取布地奈德治疗临床效果显著,值得推广和应用。
Objective To study the clinical efficacy of budesonide in the treatment of wheezing associated respiratory syncytial virus infection in children. Methods 100 cases of respiratory syncytial virus-related wheeze infants were divided into control group (45 cases) and experimental group (55 cases) according to different treatment methods. Control group to take conventional treatment, the experimental group to take budesonide treatment, the two groups compared the therapeutic effect. Results The hospitalization, wheezing improvement and respiration were improved in the experimental group (5.30 ± 0.80), (1.05 ± 0.80), (2.01 ± 0.50) and (1.80 ± 1.20) h, respectively, which were shorter than those in the control group (10.25 ± 2.20), (4.80 ± 1.03), (4.92 ± 2.60) and (5.07 ± 2.30) h respectively. The difference was statistically significant (P <0.05). FEV1, FVC and FEV1 / FVC in the control group were significantly lower than those in the experimental group (P <0.05). Conclusion The clinical efficacy of budesonide in children with respiratory syncytial virus infection is significant and worthy of promotion and application.